← Eichor
Study identifier: NCT07216495 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Pilot Study of Aerobic Exercise During Immune Checkpoint Inhibitor Therapy in Early-Stage TNBC

Condition: Aerobic Exercise · Early Stage Triple Negative Breast Cancer  ·  Sponsor: M.D. Anderson Cancer Center

PhaseNA
Planned participants33
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

To learn if participating in a supervised exercise program can help participants with early-stage TNBC who are receiving ICI therapy before undergoing breast surgery.

This description comes directly from the study's public registry record.

Talk to the study team

Salma Foster  ·  713-794-1613  ·  SYFoster@mdanderson.org

Livia Geoffrey  ·  832-728-6175  ·  LGeoffrey@mdanderson.org

Always discuss trial participation with your own doctor first.

Locations (1)

MD Anderson Cancer CenterHouston, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07216495